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Abstract
Background: Deep eosinophilic granulomatous abscesses, as distinguished from eosinophilic subcutaneous
abscesses, are rare. Most reports are from the Far-East and India where the most commonly attributed cause is
Toxocara. Sulaimaniyah in Northeastern Iraq has experienced an outbreak of eosinophilic granulomatous liver and
gastrointestinal (GI) abscesses beginning in 2009. The purpose of this study was to determine the etiology and
guide treatment.
Methods: The study was an ongoing investigation of patients having a histopathologic diagnosis of eosinophilic
granulomatous abdominal abscesses in Sulaimaniyah hospitals from May 2009 to August 2012. Tissues were
examined for organisms, and Enzyme Linked Immunoabsorbent Assays (ELISA) were performed for serum
antibodies to Fasciola hepatica, Toxocara, and Echinococcus granulosus.
Results: Fourteen patients had granulomatous inflammation surrounding a central necrotizing eosinophilic exudate
identified in surgical pathology specimens from abdominal surgeries. Two children and four adults had abscesses
that formed GI masses. These patients included a 39 year old male with oropharyngeal and transverse colon
disease, and a 48 year old male with liver and GI abscesses. All sites demonstrated a Zygomycete fungus
surrounded by eosinophilic Splendori-Hoeppli material consistent with basidiobolomycosis. Five of the six patients
with fungal disease were treated by surgery and 4 to 7 months of itraconozol. One child died of intestinal
perforation while receiving IV amphotericin B; two adults required additional surgery for recurrent GI obstruction.
Eight patients had isolated liver abscesses with no organisms identified by histopathology: ELISA results for
F. hepatica were positive for five, borderline for one, and negative for two patients. These eight patients were
treated for fascioliasis by surgical resection of localized abscesses and albendazol. One patient serologically positive
for F. Hepatica was found to have a common duct fluke two years after initial diagnosis. Serological testing for
Toxocara and Echinococcus granulosus was negative in all 14 patients.
Conclusions: Basidiobolomycosis and F. hepatica are implicated as the cause of abdominal eosinophilic
granulomatous abscesses in 12 of 14 patients identified over a period of 40 months in northern Iraq. Treatment was
complicated by chronic biliary tract disease in fascioliasis and perforation and recurrent intestinal obstruction with
basidiobolomycosis.
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Background
Eosinophilic and granulomatous liver and gastrointes-
tinal (GI) abscesses, as distinguished from Langerhans
cell disease, are barely mentioned in the pathology
textbooks [1-6]. A few articles are available from the Far
East, South America, and India where Toxocara as part
of visceral larvae migrans is implicated, although often
not proven, as being the etiologic agent [7-12]. In 2001,
eosinophilic hepatic granulomas were reported in 43
cases from the files of the Armed Forces Institute of
Pathology (AFIP) that were collected over 31 years [13].
Toxocara was identified in 30% of the specimens and
was suggested to be the causative organism for the
series. Based upon the experience with autopsies in
Uruguay, Vercelli-Retta et al. [14,15] in a following let-
ter to the editor cautioned that Fasciola hepatica may
be involved in similar cases, if not actually some
of those in the AFIP collection. The fungal disease
basidiobolomycosis is an additional cause of eosinophilic
granulomatous gastrointestinal (GI) abscesses [16-19]. GI
basidiobolomycosis affects the colon or rectum in more
than 80% of cases, but small intestinal or liver involvement
are each found in 30% of patients [19].
The liver fluke, F. hepatica, is one of the most wide-
spread of all parasites that can be transmitted to humans
[20]. It is found on all continents except Antartica, and
is a major veterinary problem with an important eco-
nomic impact on the animal reservoirs of sheep, goats,
and cattle [20-22]. Since the 1980s, human infections
have been increasingly identified with highly endemic
areas being recognized in the American Andes, the Nile
Delta, and Iran [20-26]. Outside of these endemic
regions, human fascioliasis is uncommon, but outbreaks
have been reported from Portugal and France [25,27].
F. hepatica infestations have an acute and a chronic
phase [28]. In the acute stage, immature flukes penetrate
the small intestinal wall and migrate into the liver. Most
of these immature organisms are destroyed, but after
3–4 months, those that survive mature into adult flukes
and inhabit the biliary tract where they can live for more
than a decade [28].
GI basidiobolomycosis is a rare but increasingly re-
cognized infection caused by the fungus Basidiobolus
ranarum [16]. Vikram et al. [19] reviewed the worldwide
cases reported through March 2010 and identified 44
patients diagnosed with GI basidiobolomycosis. The lar-
gest numbers of cases came from the desert climates
of Saudi Arabia (11 patients) and Arizona in the
Southwestern United States (17 patients), but four
patients each were reported from Brazil and Iran and sin-
gle patients from Nigeria, India, Bangladesh, Italy, the
Netherlands, and an unknown country [16-19]. Recently,
14 additional patients were reported from Shiraz, Iran, a
city with a climate and geography similar to Sulaimaniyah
[29]. The fungus occurs worldwide, and in the tropics,
subcutaneous eosinophilic abscesses due to the traumatic
inoculation of basidiobolomycosis are well recognized
[16]. The source of the GI infections is not known, but
pica and eating unwashed vegetables have been suggested
as predisposing factors [30].
Sulaimaniyah is the provincial capital of the eastern re-
gion of Northern Iraq. Since the 2003 Gulf War, the city
has grown rapidly and has incorporated pastoral and agri-
cultural lands where cattle, sheep, and goats are raised to-
gether with fruit and vegetable crops in close proximity to
newly developed neighborhoods. The mountain highlands
of Northern Iraq have a semi-arid summer climate much
like the Southwestern United States but with cool, wet
winters similar to endemic areas of F. hepatica in the
Andes [28].
Because deep eosinophilic granulomatous abscesses
have different causes according to the part of the world
from which they are reported, a cluster of such abdom-
inal abscesses occurring over a period of 40 months in
Sulaimaniyah, Iraq were investigated by serological and
tissue studies to identify possible infectious agents. The
findings are presented to provide physicians, surgeons,
and pathologists an awareness of deep eosinophilic
abscesses and to report our etiologic findings from this
region of the Middle-East.
Methods
The Sulaimaniyah Directorate of Health serves as the
ethics committee for Shoresh General Hospital and gave
permission for the research. The research was conducted
according to the Helsinki Accords. Written informed
consent was obtained from patients and, in the case of
children, from parents for participation in the study.
Consent was granted for using personal information and
specimen and radiographic images as case reports.
The study is a clinicopathological evaluation of patients
in which eosinophilic granulomatous inflammation not at-
tributable to Langerhans cell disease was recognized in
surgical pathology specimens. From May 2009 to August
2012, fourteen patients were identified by pathologists
(HAH, RAM, and MDH) as having liver or gastrointes-
tinal abscesses composed of eosinophilic granulomatous
inflammation. The surgical pathology specimens were
received in 10% formaldehyde in the pathology de-
partments of the two major Sulaimaniyah hospitals,
Shorsh General Hospital and the Teaching Hospital of
the University of Sulaimaniyah. None of the tissue was
received fresh and neither the pathologists nor the
surgeons submitted any specimens for bacterial or fun-
gal cultures. The gross specimens of liver were cross-
sectioned at 3–4 mm intervals and examined grossly for
larvae, round worms, or flukes. For microscopy, 4–16
blocks of tissue were obtained from the formalin-fixed
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gross specimens and serial sections were trimmed from the
paraffin blocks. The slides were stained with hematoxylin
and eosin and periodic acid-Schiff-hematoxylin (PAS-H)
stains. Microscopic slides were reviewed by all pathologists
(HAH, RAM, ABF, JG, and MDH).
With the identification of the early cases, the path-
ology was recognized as being unusual, and beginning in
May of 2010 when fungal elements were first seen,
microscopic slides and paraffin blocks were sent for con-
sultation to experts in infectious disease pathology at
Emory University, Atlanta, GA (ABF, JG). One of the
Atlanta pathologists (JG) had been involved in evaluat-
ing the Arizona basidiobolomycosis cases [16].
All patients had abdominal ultrasound examinations,
and 9 of the 14 patients had abdominal computerized
tomography (CT). Three patients with abdominal abs-
cesses (patients 1, 3, and 5) had endoscopy and endoscopic
colon biopsies before laparotomy and surgery. A stan-
dardized questionnaire was developed, and patients were
interviewed about symptoms and their time of onset, place
of residence, type of employment, diet, contact with
animals, and sources of food. Interviews were conducted
after the histopathologic diagnosis were made, and after
May 2010, before the initiation of anti-fungal or anti-
parasitic therpy. Prior to May of 2010, we did not have kits
for serological testing, and based upon our review of the
literature, three patients (7, 13, and 14) were suggested to
have Toxocara infestations and were treated with
albendazol. They were later recalled for serologic tests.
At the time of the interviews, preoperative medical
records were reviewed, blood samples were collected for
completely blood counts and serological studies, and
stool samples were examined microscopically for ova
and parasites with emphasisis on the ova of Fasciola.
Enzyme Linked Immunoabsorbent Assays (ELISA) were
performed using commercial kits for F. hepatica (Pishtaz
Teb Zaman™ Diagnostics, Tehran, Iran), Echinococcus
(Pishtaz Teb Zaman™ Diagnostics, Tehran, Iran), and
Toxocara (Diagnostic Automation™, Inc, Calabasa, CA).
All kits detected IgG antibodies to the indicated parasites
using solid phase excretory-secretory (ES) antigens. All
tests were performed in duplicate with positive and nega-
tive controls.
Irbil and Dohuk are the other large cities in the Kurdish
region that have medical reference centers. Irbil lies in the
center of the region and Duhuk in the West near the
Syrian border. HAH, RAM, and MDH have had several
discussions with the pathologists at the Hawler University
Teaching Hospitals in Irbil and the Teaching Hospital of
Dohuk University about whether they have encountered
similar cases in their Directorates with the latest queries
being by telephone in December of 2012
To find a possible source of the organisms, cattle were
investigated at the regional slaughterhouse in October
2010 by the senior consultant pathologist of Shorsh
Hospital (MDH). The livers, biliary tracts, and upper
gastrointestinal tracts of cattle processed during one day
of work were examined by serially cross sectioning the
livers and opening the duodenums and common bile
ducts.
Results
A total of 14 patients (nine males and five females) were
identified as having eosinophilic granulomatous abdom-
inal abscesses. Two of the males were 18 month old chil-
dren. The median age of the adults was 36 with a range
of 17 to 59 years old. Summaries of patient clinical,
radiological, and laboratory characteristics are provided
in Table 1 and pathology, treatment, and follow-up in-
formation in Table 2. None of the patients were diabetic
or were being treated with corticosteroids or other im-
munosuppressive drugs. HIV infections are very rare in
the Kurdish region, and none of the patients had any
HIV risk factors or had traveled outside of Iraq. Stools
were negative for ova and parasites.
Patient 1 lived in a rural mountain village to the
North of Sulaimaniyah; all other patients lived in urban
Sulaimaniyah and all had visited rural areas multiple
times within the year prior to diagnosis. Only patient 5
had any significant previous disease and had received
ongoing treatment for chronic gastritis with esome-
prazole beginning at age 25. None of the patients had
occupations related to farming, produce distribution,
or animal care. All patients ate market vegetables that
were washed with water or light soap or salt solutions.
Vinegar or potassium permanganate was not used for
washing vegetables by any of the patient’s families.
Six patients had GI ulcers that in four patients produced
tumor-like cecal and ascending colon masses composed of
eosinophilic abscesses (Figure 1). The abscesses had ir-
regularly shaped necrotic centers containing eosinophils
with variable numbers of neutrophils (Figure 2). The
margins of the abscesses were lined by a granulomatous re-
action consisting of epithelioid histiocytes and Langerhan’s
giant cells. Eosinophil crystals were occasionally but not
commonly seen. The abscesses and surrounding inflamma-
tion contained broad pauci-septate hyphae surrounded by
eosinophilic material producing the Splendore-Hoeppli
phenomenon (Figure 3). The hyphae were PAS positive
and morphologically resembled the Zygomycete fungus
Basidiobolus ranarum and were consistent with a diagnosis
of probable basidiobolomycosis (Figure 4). These patients
included a 39 year old man with ulcerating eosinophilic
granulomatous inflammation that produced extensive soft
tissue infiltration that narrowed the nasopharynx and
involved the oral cavity including the floor of the mouth,
base of the tongue, supraglottis, and glottis (Figure 5).
The severe stenosis of the laryngopharynx required a
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tracheostomy. Three months after the diagnosis of the
oropharyngeal disease, the patient developed intestinal ob-
struction and was found to have an eosinophilic granu-
lomatous mass in the transverse colon that contained
hyphae with a Splendore-Hoeppli reaction. One of the
patients with GI disease also had a localized liver abscess
containing fungus.
Eight patients had isolated eosinophilic granulomatous
liver abscesses. In 5 patients the disease was localized with
a single multilocular lesion being identified radiologically
and at laparotomy in the right hepatic lobe (Figure 6).
Localized abscesses were resected by segmental hepatic
lobectomy. In 3 patients, the disease was diffuse with
many small lesions (0.5-2 cm) being scattered throughout
the liver. The patients with diffuse small abscesses were
operated on for symptoms of gall bladder disease, and
underwent cholecystectomy and wedge biopsies of the
liver abscesses. The gall bladders showed mild chronic
cholecystitis, and by ultrasonography, the common ducts
were not dilated and contained no stones or shadows. The
Table 1 Clinical, radiologic, and laboratory characteristics of 14 patients diagnosed with granulomatous and






















Yes Yes 12% Abdominal pain/2
mos, intestinal
mass, obstruction
CT: Cecal, ascending colon
mass, stricture. Rt. lobe liver
mass
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Yes Yes 29% Abdominal pain,
pelvic mass/1 wk.
CT: Necrotic mass, lower
abdomen and pelvis
Neg









CT: Cecal mass Neg









CT: Cecal, transverse colon
masses, strictures
Neg






Yes Yes 9% Persistent cough,
sore throat/1 mo.








Yes Yes 21% Abdominal pain/2-3
d, intestinal mass,
obstruction




7. 30 M 6/2009;
histology,
serology
Janitor/healthy Yes Yes 26% R subcostal pain/1
mo.
CT: Cystic mass Rt. lobe liver.
Mild splenomegaly
Pos





No No > 50% R subcostal pain/1
wk.
US: Small hypodense liver
lesions. Mild splenomegaly
Pos







35% R subcostal pain/1-2
wks.
US: Small hypodense liver
lesions
Pos





Yes Yes 26% R subcostal pain/1-2
wks.
US: Cystic mass Rt. lobe liver Pos







72% R subcostal pain/2-3
wks.
CT: Cystic mass Rt. lobe liver.
Mild splenomegaly
Pos







74% R subcostal pain/1
wk.
US: Small hypodense liver
lesions. Mild splenomegaly
Borderline




Yes Yes 23% Abdominal pain/2-3
wks.
US: Cystic mass Rt. lobe liver.
Mild splenomegaly
Neg




No No 29% R subcostal pain/1-2
mos.
CT: Cystic mass Rt. lobe liver Neg
Abbreviations: M male, F female. Mo, month; wk, week; d, day. CT, computerized tomography; US, ultrasonography. Neg, negative; Pos, positive.
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isolated liver abscesses, both localized and diffuse,
consisted of epithelioid and mutinucleated histiocytes
surrounding irregular central zones of necrotic neu-
trophils and eosinophils with prominent elongate or
rhomboid eosinophil crystals (Figure 7). Neither larvae
suggesting Toxocara nor Fasciola flukes or ova were
found in any of the liver specimens.
Five of the 8 patients with isolated liver abscesses
tested serologically positive for F. hepatica, one had a
borderline result, and two were negative. The two nega-
tive patients had their disease identified before May of
2010 and had been treated with albendazol before having
blood drawn for serological testing 14 and 15 months
after diagnosis. One serologically positive patient had
blood drawn 13 months after being treated. All six
patients with probable basidiobolomycosis had negative
fasciola ELISA results. All 14 patients were serologically
negative for Toxocara and Echinococcus.
The adults and one child with GI basidiobolomycosis
were treated by right hemicolectomy and/or transverse
Table 2 Pathological findings, treatment, and follow-up for 14 patients diagnosed with granulomatous and
eosinophilic gastrointestinal and hepatic abscesses in Sulaimaniyah, Iraq, 2009–2012




































4. Right hemi and transverse
colectomy
















d, Oral 7 mos
None Asymptomatic,
7 mos.












Liver, diffuse abscesses 0.5-2 cm No Albendazole





Liver, diffuse abscesses 0.5-2 cm No Albendazole
400 mg/d, 3 d
Common duct
fluke after 2 yrs
Asymptomatic,
30 mos.
10. Segmental hepatectomy Liver mass, localized 3 cm No Albendazole
400 mg/d, 3 d
None Asymptomatic,
28 mos.
11. Segmental hepatectomy Liver mass, localized 5 cm No Albendazole





Liver, diffuse abscesses 0.5-2 cm No Albendazole
400 mg/d, 3 d
None Asymptomatic,
30 mos.
13. Segmental hepatectomy Liver mass, localized 4x5 cm No Albendazole
400 mg/d, 3 d
None Asymptomatic,
42 mos.
14. Segmental hepatectomy Liver mass, localized 2 cm No Albendazole
400 mg/d, 3 d
None Asymptomatic,
43 mos.
Abbreviations: Mo, month d, day.
Figure 1 Patient 1. A right hemicolectomy specimen showing a
cecal mass with irregular mucosal ulceration.
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colectomy for the GI masses, and for the patient with liver
involvement by segmental hepatectomy. Surgery was
followed by oral itraconozol at 400 mg/day for 4 to 7
months. Two adults required additional surgery for recur-
rent intestinal obstruction, one at 3 months and the other
at 5 months following the original colonic resection. One
of the children (patient 2) developed intestinal perforation
and died while he was receiving intravenous amphotericin
B. Intravenous itraconozol was not available, and the child
was too ill to undergo extensive surgery at the time
basidiobolomycosis was diagnosed on the basis of an inci-
sional biopsy obtained at laparotomy from the outer as-
pect of a large pelvic mass. Intravenous itraconozole was
obtained for the patient with oropharyngeal disease. After
two months, the tissues of the oropharynx decreased in
size, and airway and esophageal access were restored. The
infected segment of transverse colon, that was found three
months after beginning treatment of the oropharyngeal
disease, was resected, and the patient continued 7 months
of oral itraconozle with no further complications.
After surgery, patients with isolated liver abscesses in-
cluding those with positive, borderline, and negative
fasciola ELISA results were treated with a 3 day course
of 400 mg daily of albendazole. Constitutional symptoms
resolved within the 3 day period of treatment and eo-
sinophilia within one to 3 months afterward. Two years
after her initial treatment, patient 10 developed right
Figure 2 Patient 1. The wall of the cecum demonstrates a stellate
abscess with a necrotic center containing eosinophils surrounded by
granulomatous inflammation with Langerhans giant cells. Fungal
elements can be seen surrounded by an eosinophilic Splendore-
Hoeppli reaction. Hematoxylin and eosin stain ×100.
Figure 3 Patient 5. The microscopy of a tonsilar biopsy reveals an
intense eosinophilic inflammatory reaction containing fungal hyphae
surrounded by the Splendore-Hoeppli phenomenon. Hematoxylin
and eosin stain ×200.
Figure 4 Patient 1. The fungi consist of broad pauci septate
hyphae consistent with basidiobolomycosis. Periodic acid-Schiff
hematoxylin stain ×400.
Figure 5 Patient 5. Magnetic resonance imaging showing a mass
at the base of the tongue that markedly narrows and shifts the
oropharynx laterally.
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upper quadrant pain and tenderness and was found to
have a dilated common duct with a moving shadow by
ultrasonography. A fluke was extracted from her com-
mon bile duct by ERCP. She was then given a single
dose of 500 mg of triclabendazole and has since been
asymptomatic and has had no eosinophilia.
Most of the patients came to medical attention during
the warmer and dryer months of the year. The patients
with probable basidiobolomycosis were diagnosed in
February, May (2 patients), August (2 patients), and
October. Patients serologically positive or borderline for
F. hepatica were diagnosed in May (one positive, one
borderline), June (2 patients), August, and November.
The two patients with isolated liver abscesses and nega-
tive fasciola serology were diagnosed in April and May.
Since beginning the study, we have had one case of
cutaneous chromoblastomycosis and two cases of
aspergillus allergic fungal sinusitis, but have not seen
any eosinophilic subcutaneous abscesses nor any sub-
cutaneous or sinus fungal infections consistent with
entomophthoromycosis. We have had one case of inva-
sive sino-nasal mucormycosis in a diabetic. Cancer
chemotherapy patients are usually investigated by bron-
chial washings or fine needle aspiration cytology rather
than biopsies for pulmonary infections. With this limi-
tation, we have had only two bronchial washes
containing Candida as potential fungal pulmonary
infections. Endoscopic colon biopsies before laparotomy
on patients 1, 3, and 5 showed eosinophilic granuloma-
tous inflammation; fungi were seen only in the biopsy of
patient 5. One eosinophilic liver abscess was reported
at the Teaching Hospital of Duhuk University in
2010; none have been seen by the pathologists at
Hawler University Teaching Hospitals in Erbil.
Thirty seven cattle were examined at the Sulaimaniyah
slaughterhouse and F. hepatica was identified in ten
animals (27%). Immature flukes were found in the duo-
denums, and adult flukes were identified in thickened
intrahepatic bile ducts (Figure 8). None of the cattle
showed any evidence of fungal disease.
Discussion
In this article, we report from Northern Iraq a cluster of
GI and hepatic eosinophilic granulomatous abscesses
that were not recognized in the region prior to 2009.
This pathology is relatively rare, and the medical litera-
ture is vague about possible causative agents. We show
that, in this region of Iraq, some eosinophilic granu-
lomatous abscesses can be attributed to F. hepatica
and others to a fungus consistent with Basidiobolus
ranarum. Although, two of the 14 cases could not be
ascribed to a specific etiologic agent, none of the
patients had serological or pathological evidence for
Toxocara or Echinococcus granulosis, the latter being the
most common clinical parasitic disease of the region
[31,32].
The currently recommended criteria for the diagnosis
of fascioliasis include peripheral eosinophilia and posi-
tive serological testing for antibodies to the organism
[33,34]. Additional symptoms of the acute hepatic stage
consist of fever, malaise, right subchondral pain, and
weight loss. CT may show irregular hypodense lesions
within the liver [35]. Stool examinations for eggs can be
diagnostic but are usually negative because of a generally
low concentration of adult flukes and irregular shedding
of eggs [34]. The immature flukes that penetrate the
Figure 6 Patient 7. Localized abscess of the right lobe of the liver
in a patient serologically positive for F. hepatica.
Figure 7 Patient 7. The abscess consists of a peripheral rim of
epithelioid histiocytes and central necrosis with neutrophils and
eosinophils. Numerous eosinophil crystals are present. Hematoxylin
and eosin ×400.
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liver are rarely seen in histologic sections, and a tissue
diagnosis of fascioliasis is usually not possible [15,28].
On the basis of the serological findings, five of the 14
patients with eosinophilc abscesses were diagnosed as hav-
ing F. hepatica infestations. On the basis of a borderline
serological result, one additional patient was considered to
be suspicious for fascioliasis. All 6 of these patients
presented with right subcostal abdominal pain and eosino-
philia. By CT or ultrasonography, a 3 to 6 cm in diameter
cystic mass was found in the right lobe of the liver in 3
patients, and small hypodense lesions were scattered
thoughout the liver in 3 other patients. The surgical path-
ology specimens of both the larger and the smaller lesions
demonstrated eosinophilic granulomatous abscesses with
no evidence of flukes or ova.
In six patients, the eosinophilic abscesses contained
pauci-septate hyphae surrounded by a Splendore-
Hoeppli reaction. While a definitive diagnosis requires
culture, a probable diagnosis of basidiobolomycosis can
be made histologically [30]. The species Basidiobolus
ranarum is a Zygomycete fungus belonging to the or-
der Entomophthorales [36]. The differential diagnosis
consists of the entomophthoromycosis Conidiobolus
coronatus and Conidiobolus incongruous that like basi-
diobolomycosis incites an eosinophilic granulomatous
tissue reaction and the Splendore-Hoeplli pheno-
monon. Conidiobolus is primarily a tropical disease that
produces sinonasal infections and subcutaneous abs-
cesses. Oropharyngeal and laryngeal disease has been
reported, but Conidiobolus is not a known cause of
intestinal infections [36]. Vikram et al. [19] have
recommended that the definition of probable GI
basidiobolomycosis include the identification of disease
at a site below the esophagus in the stomach, large or
small intestine, anus, liver, gall bladder, or pancreas.
In this current study, patients with probable basi-
diobolomycosis had fever, malaise, weight loss, and mild
to moderate eosinophilia, but the predominant finding
was an abdominal mass with intestinal obstruction. One
patient had an ulcerating oropharyngeal and glottic mass
and obstructing disease of the transverse colon. This oro-
pharyngeal disease was included as an example of GI
basidiobolomycosis on the basis of the patient's colon in-
volvement and on the basis of the definition of the GI
tract by the National Library of Medicine-Medical Subject
Headings including all derivatives of the embryonic
entoderm from the mouth to the anus [37]. As an example
of probable oropharyngeal basidiobolomycosis, the case
extends the reported level of GI involvement to above
the stomach and overlaps with locations infected by
Conidiobolus [19,36].
It is suggested that GI basidiobolomycosis is acquired
by the ingestion of contaminated soil or animal fecal
material [16]. The animal herds at the outskirts of
Sulaimaniyah make dung ubiquitous, and the dry cli-
mactic conditions throughout the warm months of the
year may contribute to the windborne spread of
organisms [16]. It is notable that five of the six patients
with basidiobolomycosis were diagnosed in May, August
and October, and that currently GI basidiobolomycosis
is the most common deep fungal infection diagnosed in
our community. It is also notable that cutaneous ento-
mophthoromycosis, that is rare in arid climates where
the great majority of GI basidiobolomycosis is reported,
has not been seen in Sulaimaniyah.
In past years, sporadic cases of the biliary phase of
fascioliasis have been recognized in the Sulaimaniyah
governate, and in the autumn of 2007, one of the
authors (TAH) conducted a study of local streams and
identified F. hepatica rediae in 4% of Lymnaeid snails
[38]. Rediae develop into tadpole-like cercariae that
leave the snail and encyst as metacercariae on vegeta-
tion in or near streams and rivers [24,27,39]. Naturally
growing watercress is sold in Sulaimaniyah markets. It
is a favourite vegetable for human consumption with
both wild and commercial products being common
sources of infection [27,39]. Studies of hyperendemic
fascioliasis in the South American Andes indicate that
an increased risk of livestock infection and human
transmission can be anticipated when greater numbers
of cattle become concentrated around limited water
sources [24]. As part of our current study, we found that
27% of cattle being processed at the regional slaughter
house were infected with F. hepatica. The growth of
Sulaimaniyah into areas still used for livestock may have
Figure 8 Liver of a bull slaughtered at the regional abattoir
showing an adult fluke of F. hepatica that was found in the
thickened bile duct below the parasite.
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exacerbated a generally low endemic level into one ex-
posing increased numbers of humans to infection.
The acute phase of Fasciola hepatica responds well
to a single course of triclabendazole [40]. Although
triclabendazole has not been available in our pharma-
cies, symptoms and eosinophilia resolved with a 3 day
course of 400mg of albendazole. Nevertheless, one of
the patients treated with albendazole entered a chronic
biliary phase of the disease two years after the initial
diagnosis. Fatal fascioliasis occurs in livestock that are
infected with large numbers of organisms, but this is
extremely rare in humans for whom the principal
manifestations are a prolonged low-grade febrile illness
with some degree of anemia and hepatomegaly [28,41]
The reported cases of GI basidiobolomycosis nearly all
had large or small intestinal obstruction that required
surgery [19,29]. The recommended treatment is surgical
removal of the infected tissues and an imidazole as anti-
fungal agent with itraconozole being the most frequently
recommended [16,19,36]. The organism tends to be re-
sistant to amphotericin B [16,19,36]. In the review by
Vikram et al. [19], eight deaths occurred among four-
four patients (18%) with five of the fatalities being chil-
dren [16-19,42-44]. Common features of the fatal cases
were intestinal perforation and/or extensive abdominal
spread of the disease [18,43]. Of the patients who died,
only one was treated with itraconozole, 4 received no
anti-fungal therapy, and 3 patients an amphotericin
product. In our fatal case, the patient received ampho-
tericin B as an anti-fungal agent and died as a result of
intestinal perforation before the infected tissue could be
resected.
The clinicopathologic findings for the two patients in
which no diagnosis could be established were similar to
those diagnosed with fascioliasis. The patients had isolated
hepatic abscesses, abdominal pain, and eosinophila. Both
patients were treated with albendazole for presumed toxo-
cariasis more than a year before they were tested sero-
logically. Following eradication of organisms, the ELISA
serology for Fasciola is reported to become negative in
40% of patients at 6 months and more than 90% of
patients after 12 months [45]. In contrast, anti-Toxocara
IgG antibodies in patients treated for visceral toxocariasis
usually remain elevated for years [46,47]. We recognize
that an organism other than F. hepatica may have caused
the two etiologically undiagnosed cases, but with the nega-
tive serology and inability to find larvae in the abscesses,
we believe that a role for Toxocara has been reasonably
Table 3 Pathological and clinical laboratory findings in the differential diagnosis of abdominal eosinophilic
granulomatous abscesses







80% of patients Rare, ectopic Not reported [16,19,46,48,49]
Liver abscesses Localized, 30% of patients Diffuse more common than
localized.







Present Present Present [12-16,19,28]
Eosinophils Present Present Present [12-16,19,28]
Charcot-Leyden
crystals
Not prominent Numerous Present [12-16,19,28]
Organisms in
tissues
Pauci-septate hyphae with Splendore-
Hoeppli reaction required for diagnosis
Very rare, if present ova more
common than flukes
Larvae 30% of cases [12-16,19,28,46,50]
Clinical laboratory
findings








Immunodiffusion positive 50% of
patients, not routinely available.
ELISA 87-93% sensitivity, 98%
specificity for acute stage
ELISA 78% sensitivity, 98%
specificity for VLM
[16,19,33,47,50]
After treatment Unknown > 90% negative at 1 year. Positive for years after VLM [16,19,33,45-47]
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ruled out and that these patients may have had fascioliasis
with an attenuated antibody response.
In order to reach a correct diagnosis and determine
the cause of an eosinophilic granulomatous abdominal
abscess, pathologists, surgeons, and physicians should be
aware of the different possible etiologies. A presentation
as a GI mass must be distinguished from cancer, and the
granulomatous inflammation surrounding the central
abscess can be mistaken for tuberculosis. We have seen
the eosinophilia of fascioliasis erroneously treated as an
idiopathic hypereosinophilia syndrome with imatinib
mesylate.
The fungus of basidiobolomycosis is readily identified
if sufficient tissue is obtained but can be missed in mu-
cosal biopsies as it was in two of our patients. The diag-
nosis of fascioliasis has historically been a problem.
Serological testing is often unavailable, or an ineffective
method may used. Before 2003, the sensitivity of sero-
logical tests was poor, but newer ELISA kits using ES or
Fas2 antigens have an estimated sensitivity of 87-93%
and are currently the recommended methods for diag-
nosing F. hepatica [33,34,40,45].
The gastrointestinal location of an eosinophilic granu-
lomatous mass points to basidiobolomycosis, but rare
examples of ectopic fascioliasis producing tumor-like co-
lonic masses are reported [28,48,49]. In addition, hepa-
tic abscesses are found in a significant proportion of
patients with basidiobolomycosis [19]. It is not the loca-
tion of eosinophilic granulomatous disease, but the iden-
tification of an Entomophthorales fungus that provides
for the diagnosis of basidiobolomycosis, and the absence
of fungus and a positive serological test for Fasciola that
allows for the diagnosis of fascioliasis. Table 3 sum-
marizes the pathological and serological findings for
basidiobolomycosis, fascioliasis, and toxocariasis, the
latter being included because it is considered a fre-
quent cause of eosinophic granulomatous liver abscesses
[9-11,13,46,50].
The identification of disease at surgery uncovers only
the most severely affected patients. Serological studies for
F. hepatica in the urban and rural populations of
Sulaimaniyah as well as the examination of livestock are
currently in progress to determine the level of the ende-
mic situation. The clustering of basidiobolomycosis and
F. hepatica has not been previously reported. The epi-
demiology of F. hepatica has been thoroughly studied but
factors predisposing to basidiobolomycosis are poorly
understood [16,20-25,30]. We believe Sulaimaniyah may
provide an opportunity to identify conditions that contrib-
ute to human outbreaks of both diseases.
Conclusions
Eosinophilic granulomatous abscesses unrelated to
Langerhans histiocytosis are relatively rare human diseases
of often obscure etiology. The city of Sulaimaniyah in the
Eastern Kurdish region of Northern Iraq has experienced
an outbreak of 14 of these lesions over a period of 40
months. Isolated liver abscesses attributable to F. hepatica
were found in 6 of the 14 patients with the parasite also
being identified in local cattle and as an endemic infest-
ation of snails in local streams. Ulcerating GI abscesses
caused by a Zygomycete fungus consistent with basidio-
bolomycosis occurred in 6 of the 14 patients. These two
diseases have not been previously reported as occurring at
the same time in the same region. The mode of transmis-
sion of basidiobolomycosis to humans is unknown, but
the emergence in Sulaimaniyah together with fascioliasis
supports the suggestion that basidiobolomycosis may be
transmitted by the feces of grazing animals [16].
Limitations
The study is observational and descriptive. As a descrip-
tive study, it presents a relatively small number of
patients that may bias generalizations regarding treat-
ment, outcomes, and general manifestations of the
diseases. The study is further limited by the lack of fun-
gal cultures for the organism identified by histology as
probable basidiobolomycosis.
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